banner

Posts tagged as: merger and acquisition news back to homepage

Xstrata and Glencore Agree to Merger Terms, Shareholders Disagree with Deal Xstrata and Glencore Agree to Merger Terms, Shareholders Disagree with Deal(0)

The discussion talks were confirmed last week by Xstrata PLC (LSE:XTA, Pink Sheets:XSRAY) that it and Glencore International PLC (LSE:GLEN) were considering a merger, although careful to say that no assurance was given that a deal would ever materialize.  This morning, that deal came public with the two industry giants agreeing to merge in an all-share deal that would create a $90 billion natural resources behemoth. Read More

Valeant Pulls Offer to Buy ISTA Pharmaceuticals Valeant Pulls Offer to Buy ISTA Pharmaceuticals(0)

As a result of what Valeant Pharmaceuticals International Inc. (NYSE:VRX, TSX:VRX) called “a lack of progress,” Valeant has withdrawn its offer to buy ISTA Pharmaceuticals Inc. (NASDAQ:ISTA) for $7.50 a share in cash.

Valeant had been aggressive in its efforts to acquire California-based ISTA, increasing the offer from $6.50 to $7.50 earlier this month and stating that the offer could go as high as Read More

Everything for Less Equals More, Pep Boys Accepts Offer at $15 A Share Everything for Less Equals More, Pep Boys Accepts Offer at $15 A Share(0)

Pep Boys may have everything for less, but today they got more. Pep Boys – Manny Moe & Jack (NYSE:PBY), the U.S.’s largest automotive aftermarket service and retail chain said this morning that it is going private via a definitive merger agreement to be acquired by The Gores Group, one of the country’s leading investment firms. The agreement is valued at approximately $1 billion, or $15 per share for holders of PBY. Read More



Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.